(Q40492153)

English

Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma (English)

1 reference

Europe PubMed Central

21 September 2017

Human T-lymphotropic virus 1

0 references

Olivier Hermine

10

1 reference

Europe PubMed Central

21 September 2017

9

object named as

Hugues de Thé

0 references

Yves Lepelletier

object named as

Yves Lepelletier

7

0 references

object named as

Ali Bazarbachi

11

0 references

5

object named as

Youmna Kfoury

1 reference

Europe PubMed Central

21 September 2017

1

object named as

Rihab Nasr

1 reference

Europe PubMed Central

21 September 2017

author name string

Marwan E El-Sabban

2

1 reference

Europe PubMed Central

21 September 2017

José-Antonio Karam

3

1 reference

Europe PubMed Central

21 September 2017

Ghassan Dbaibo

4

1 reference

Europe PubMed Central

21 September 2017

Bertrand Arnulf

6

1 reference

Europe PubMed Central

21 September 2017

Françoise Bex

8

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 January 2005

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

24

1 reference

Europe PubMed Central

21 September 2017

419-430

1 reference

Europe PubMed Central

21 September 2017

3

1 reference

Europe PubMed Central

21 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208212

0 references

The proteasome: structure, function, and role in the cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

NF-kappa B: ten years after

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

The immune response to HTLV-I.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Determination of ceramides and diglycerides by the diglyceride kinase assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Missing pieces in the NF-kappaB puzzle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Functions of ceramide in coordinating cellular responses to stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (LRP) genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Selective protein degradation: a journey's end within the proteasome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

p21(Waf1/Cip1/Sdi1) prevents apoptosis as well as stimulates growth in cells transformed or immortalized by human T-cell leukemia virus type 1-encoded tax.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Presentation of a new H-2D(k)-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Caspase activity is required for stimulated B lymphocytes to enter the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Human T-cell leukemia virus type I Tax activation of NF-kappa B/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p65)-mediated induction of the c-rel gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Activation of I-kappaB kinase by the HTLV type 1 Tax protein: mechanistic insights into the adaptor function of IKKgamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Multiple viral strategies of HTLV-1 for dysregulation of cell growth control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

21 January 2018

Programmed cell death induced by ceramide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208212

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1208212

1 reference

Europe PubMed Central

21 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40492153&oldid=1898141929"